Tecfidera and Jardiance drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tecfidera (dimethyl fumarate) and Jardiance (empagliflozin). Common drug interactions include stress among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Tecfidera and Jardiance. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.
What is Tecfidera?
Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.
What is Jardiance?
Jardiance has active ingredients of empagliflozin. It is often used in hyperglycemia. eHealthMe is studying from 44,459 Jardiance users. Check the latest studies of Jardiance.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
41 people who take Tecfidera and Jardiance together, and have interactions are studied.

What are the common drug interactions of Tecfidera and Jardiance, by gender? *:
female:
- Stress
- Urinary tract infection
- White blood cell count decreased
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood glucose decreased
- Hypersensitivity
- Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
- Peripheral swelling
- Red blood cell count decreased
- Renal disorder (kidney disease)
male:
- Diarrhoea
- Abdominal discomfort
- Intervertebral disc disorder (spinal disc disorder)
- Intervertebral disc protrusion (spinal disc protrusion)
- Speech disorder
- Spinal osteoarthritis (joint cartilage loss in spine)
- Spinal stenosis (narrowing of spinal column)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Weight decreased
- Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
What are the common drug interactions of Tecfidera and Jardiance, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Diarrhoea
- Faeces discoloured
- Loss of consciousness
- Weight decreased
- Abdominal discomfort
- Blood glucose decreased
- Blood glucose increased
50-59:
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hot flush (sudden feelings of heat)
- Abdominal discomfort
- Burning sensation
- Pruritus (severe itching of the skin)
- Anxiety
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Blood glucose increased
- Constipation
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
60+:
- Hypoaesthesia (reduced sense of touch or sensation)
- Back disorder
- Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Optic nerve injury
- Platelet count decreased
- Stress
- Type 2 diabetes mellitus
- Urinary tract infection
- White blood cell count decreased
What are the existing conditions these people have? *
- Diabetes: 8 people, 19.51%
- High Blood Cholesterol: 3 people, 7.32%
- Gait Disturbance: 3 people, 7.32%
- Chest Pain: 3 people, 7.32%
* Approximation only. Some reports may have incomplete information.
Do you take Tecfidera and Jardiance?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tecfidera and Jardiance:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tecfidera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Jardiance:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tecfidera and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Jardiance and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dimethyl fumarate and empagliflozin (the active ingredients of Tecfidera and Jardiance, respectively), and Tecfidera and Jardiance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Unisom vs. Neurontin, side effect and effectiveness comparison - 35 seconds ago
- Drug interactions of Celecoxib and Dapsone - 46 seconds ago
- Flovent and Tylenol drug interactions for men aged 60+ - 47 seconds ago
- Cytomegalovirus Infection and Hepatic Failure - 47 seconds ago
- Could Nifedipine cause Neuroleptic Malignant Syndrome? - 52 seconds ago
- Drug interactions of Ranitidine and Acthar - 55 seconds ago
- Could Spironolactone cause Pco2 Decreased? - 58 seconds ago
- Clonidine and Lexapro drug interactions for men aged 30-39 - a minute ago
- Could Hydrochlorothiazide cause Chronic Fatigue Syndrome? - a minute ago
- Could Sudafed cause Neutrophil Count Decreased? - a minute ago